Health World Mauritania: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health World Mauritania.

Press releases published on September 24, 2026

6 hours ago

New Preclinical Data Further Support Potential for Tvardi’s STAT3 Inhibitors in Ulcerative Colitis (UC)

Indeterminate GlobeNewswire

6 hours ago

Annexon to Present Patient Baseline Characteristics from Vonaprument Phase 3 ARCHER II Pivotal Trial for Geographic Atrophy at The Retina Society 59th Annual Scientific Meeting

Indeterminate GlobeNewswire

6 hours ago

Sofwave Receives NMPA Approval in Mainland China

Indeterminate GlobeNewswire

6 hours ago

Immuneering to Present at the ESMO Congress 2026

Indeterminate GlobeNewswire

6 hours ago

Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products

Indeterminate GlobeNewswire

6 hours ago

Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October

Indeterminate GlobeNewswire

6 hours ago

Kraig Biocraft Laboratories Reaches Major Scientific Milestone with Completion of Functional and Living Atlas Gene Library

Indeterminate GlobeNewswire

7 hours ago

Coave Therapeutics to Present New Data on Wet AMD Gene Therapy Program at 26th Euretina Congress as it Advances towards the Clinic

Indeterminate GlobeNewswire

7 hours ago

Atavistik Bio Announces Strategic Research Collaboration with Roche to Discover and Develop Novel Allosteric Therapeutics

Indeterminate GlobeNewswire

7 hours ago

Medicenna Announces Oral Presentation of New Bizaxofusp Results in Recurrent Glioblastoma at the 2026 Society for Neuro-Oncology Annual Meeting

Indeterminate GlobeNewswire

7 hours ago

What CX Leaders Should Understand About Customer Support Outsourcing

Indeterminate GlobeNewswire

7 hours ago

Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (FSHD) and a Partnership with FSHD Canada Foundation Providing Non-Dilutive Financing to Support Clinical Development

Indeterminate GlobeNewswire

7 hours ago

Vistagen Reports Positive Findings Supporting Fasedienol’s Potential in Very Severe Social Anxiety Disorder

Indeterminate GlobeNewswire

7 hours ago

Cullinan Therapeutics Highlights Fourth Quarter 2026 Milestones Across Immunology and Oncology T Cell Engager Portfolio

Indeterminate GlobeNewswire

7 hours ago

Ligand and AvenCell Therapeutics Enter Financing Agreement to Advance Pipeline of Next-Generation CAR-T Therapies for Up to $47 Million

Indeterminate GlobeNewswire

7 hours ago

PridCor Therapeutics Advances Phase 2 SHIELD Study of a Combination Antiviral Regimen for Long COVID Toward Enrollment

Indeterminate GlobeNewswire

7 hours ago

Mesoblast Receives FDA Approval for New Potency Assay to Release Commercial Ryoncil Product

Indeterminate GlobeNewswire

7 hours ago

Amesite Announces New Sales Win Under NurseMagic® Minimum Enterprise Pricing Model

Indeterminate GlobeNewswire

8 hours ago

Kyverna Therapeutics Reports Positive One-Year Data Demonstrating Durable Clinical Responses and Favorable Safety Profile for Miv-cel in Stiff Person Syndrome and Generalized Myasthenia Gravis

Indeterminate GlobeNewswire

8 hours ago

MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast)

Indeterminate GlobeNewswire